Loading viewer...
earnings
Format: PDF earnings
Viatris Inc. presents Q1 2024 earnings results with updates on the Idorsia collaboration adding two phase 3 assets, pipeline expansion in eye care and complex injectables, and 2024 financial guidance. The company details strategic initiatives including ongoing divestitures, debt reduction plans targeting investment grade credit rating, and capital allocation framework.
earnings
46 Pages
earnings
30 Pages
Axiata Group Berhad
IOL Chemicals and Pharmaceuticals Q4 FY2022 Investor Presentation May 2022
earningsearnings
25 Pages
IOL Chemicals and Pharmaceuticals Limited
Trimas Corporation Q2 2016 Earnings Presentation
earningsearnings
36 Pages
Trimas Corporation
Pacific Edge HY17 Interim Results 2016
earningsearnings
24 Pages
Pacific Edge Limited